About PharmaCCX
PharmaCCX is a private company based in Boston, Massachusetts. It has reported $11,656,798 raised in three offerings on Form D since November 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 26, 2023 | Jul 18, 2023 | $5,396,496of $5.4M target | 24 | $224K | EquityRule 506(b) | Form D ↗ |
| Mar 6, 2020 | Mar 19, 2020 | $3,000,004of $7.0M target | 4 | $750K | EquityRule 506(b) | Form D ↗ |
| Nov 13, 2018 | Nov 27, 2018 | $3,260,298of $4.0M target | 16 | $203K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $11,656,798 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on PharmaCCX's Form D filed Jul 18, 2023.
PR
Peter Rice
President
NS
Nathan Sigworth
Executive officer and director
JB
Julia Bernstein
Director
RK
Rob Kniaz
Director
BS
Barath Subramanian
Director
Earlier filings also listed Armen Solakhyan (executive officer, last listed Mar 2020).